CORE--ANALYTIC
CORE--ANALYTIC
批准号:
7864197
负责人:
NOURI NEAMATI
金额:
$20.93万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
Alzheimer&aposs DiseaseAlzheimer&aposs disease modelAnimalsBioinformaticsBloodBrainBrain regionCatalogingCatalogsCluster AnalysisCustomDiscriminationElectronsEnsureFutureGasesGene ExpressionGenesHippocampus (Brain)Hormone AntagonistsHormonesIndividualLiquid substanceMass Spectrum AnalysisMenopauseModelingMusPathway interactionsPatternPattern RecognitionPerimenopausePharmacologic SubstancePlasmaProcessProgesteroneProteinsRNA ProcessingRadioimmunoassayRattusResearchResearch PersonnelReverse Transcriptase Polymerase Chain ReactionSamplingScienceSerumServicesSolutionsSpecimenSpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationTimeTissue BankingTissue BanksTissue SampleTissuesTranslational ResearchUrineUterusaging brainbrain tissuecomputational chemistrydetectorhormone metabolisminhibitor/antagonistionizationmemberprofessorprogramsresearch study
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Core C: Analytic
The Analytical Core, under the direction of Dr. Nouri Neamati, Assistant Professor of
Pharmaceutical Sciences, will process, bank, and analyze all tissues and appropriate samples for
research purposes for use in this Program Project. The tissues as well as fluid, specimens including
blood, serum, and urine will be collected where needed for individual investigators with hypothesis
driven translational research. The Analytical Core will provide the following services where
appropriate:
1) Macroarray analysis of 100 highly relevant customized genes using SuperArray platform.
2) Real-Time PCR for selected genes.
3) Mass Spectrometry including MALDI and MS/MS analysis for selected samples.
4) Progesterone and metabolite analysis by Gas Chromatograph with Mass Selective Detector
utilizing Electron Impact ionization, and 5) Quantitative analysis of progesterone and metabolites by
radioimmunoassays.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Preclinical Development of First-in-Class NDUFS7 Antagonists for the Treatment of Pancreatic Cancer
-
批准号:10684845
-
项目类别:
-
资助金额:$46.36万
-
财政年份:2022
-
负责人:NOURI NEAMATI
-
依托单位:
Preclinical Development of First-in-Class GSTO1 Degraders for Colorectal Cancer
-
批准号:10675586
-
项目类别:
-
资助金额:$53.14万
-
财政年份:2022
-
负责人:NOURI NEAMATI
-
依托单位:
gp130 as a novel therapeutic target in ovarian cancer
-
批准号:8797755
-
项目类别:
-
资助金额:$37.69万
-
财政年份:2015
-
负责人:NOURI NEAMATI
-
依托单位:
Efficacy of PDI inhibitors in glioblastoma
-
批准号:8858876
-
项目类别:
-
资助金额:$48.63万
-
财政年份:2015
-
负责人:NOURI NEAMATI
-
依托单位:
gp130 as a novel therapeutic target in ovarian cancer
-
批准号:8994723
-
项目类别:
-
资助金额:$37.63万
-
财政年份:2015
-
负责人:NOURI NEAMATI
-
依托单位:
ROS-targeted therapy for pancreatic cancer
-
批准号:9102041
-
项目类别:
-
资助金额:$46.1万
-
财政年份:2015
-
负责人:NOURI NEAMATI
-
依托单位:
gp130 as a novel therapeutic target in ovarian cancer
-
批准号:9903250
-
项目类别:
-
资助金额:$36.5万
-
财政年份:2015
-
负责人:NOURI NEAMATI
-
依托单位:
Efficacy of PDI inhibitors in glioblastoma
-
批准号:9086289
-
项目类别:
-
资助金额:$48.61万
-
财政年份:2015
-
负责人:NOURI NEAMATI
-
依托单位:
ROS-targeted therapy for pancreatic cancer
-
批准号:8963517
-
项目类别:
-
资助金额:$46.1万
-
财政年份:2015
-
负责人:NOURI NEAMATI
-
依托单位:
High Throughput Screen for Myotonic Dystrophy Type 1
-
批准号:8209483
-
项目类别:
-
资助金额:$4.08万
-
财政年份:2011
-
负责人:NOURI NEAMATI
-
依托单位:
Inhibition of HIV-1 Integrase-LEDGF/P75 Interactions
-
批准号:7897668
-
项目类别:
-
资助金额:$20.4万
-
财政年份:2009
-
负责人:NOURI NEAMATI
-
依托单位:
Inhibition of HIV-1 Integrase-LEDGF/P75 Interactions
-
批准号:7756315
-
项目类别:
-
资助金额:$24.6万
-
财政年份:2009
-
负责人:NOURI NEAMATI
-
依托单位:
Integrin avb3 targeted drug design, delivery, and imaging
-
批准号:8136333
-
项目类别:
-
资助金额:$20.69万
-
财政年份:2007
-
负责人:NOURI NEAMATI
-
依托单位:
Integrin avb3 targeted drug design, delivery, and imaging
-
批准号:7384532
-
项目类别:
-
资助金额:$22.98万
-
财政年份:2007
-
负责人:NOURI NEAMATI
-
依托单位:
Integrin avb3 targeted drug design, delivery, and imaging
-
批准号:7663242
-
项目类别:
-
资助金额:$21.4万
-
财政年份:2007
-
负责人:NOURI NEAMATI
-
依托单位:
Integrin avb3 targeted drug design, delivery, and imaging
-
批准号:7502581
-
项目类别:
-
资助金额:$21.4万
-
财政年份:2007
-
负责人:NOURI NEAMATI
-
依托单位:
Integrin avb3 targeted drug design, delivery, and imaging
-
批准号:7901354
-
项目类别:
-
资助金额:$21.33万
-
财政年份:2007
-
负责人:NOURI NEAMATI
-
依托单位:
CORE--ANALYTIC
-
批准号:7082602
-
项目类别:
-
资助金额:$13.04万
-
财政年份:2006
-
负责人:NOURI NEAMATI
-
依托单位:
CORE--ANALYTIC
-
批准号:7626295
-
项目类别:
-
资助金额:$20.37万
-
财政年份:--
-
负责人:NOURI NEAMATI
-
依托单位:
CORE--ANALYTIC
-
批准号:7447872
-
项目类别:
-
资助金额:$20.18万
-
财政年份:--
-
负责人:NOURI NEAMATI
-
依托单位:
国内基金
海外基金
新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
-
批准号:81000622
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2010
-
负责人:梁胜
-
依托单位:
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
-
批准号:31060293
-
项目类别:地区科学基金项目
-
资助金额:26.0万元
-
批准年份:2010
-
负责人:郭亚芬
-
依托单位:
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究
-
批准号:30960334
-
项目类别:地区科学基金项目
-
资助金额:22.0万元
-
批准年份:2009
-
负责人:董贵成
-
依托单位: